8/16/2023 0 Comments Endo pharma slalom![]() We believe our Values – Collaboration, Innovation, Integrity & Quality, Drive and Empathy – are more than words on a page, and that how we work is as important as what we achieve," said Blaise Coleman, President and CEO of Endo. ![]() Attorney General Herbert Slatery also is in a leadership role among a group of state attorneys general investigating various opioid manufacturers and distributors and negotiating possible settlements."At Endo, we are motivated by a strong sense of purpose. "It’s very rare, but then again, rarely do you see the kind of behavior and actions taken by counsel and a defendant as outlined in that order,” District Attorney General Barry Staubus, one of the plaintiffs, said of the default judgment.Īt the state level, Tennessee has sued several companies over the opioid epidemic. “Plaintiffs should not be forced to choose between going to trial without this highly relevant information - which Endo and its attorneys intentionally hid from Plaintiffs and this Court - or delaying the trial for months or even a year,” Moody wrote.Īdditionally, Moody wrote that the company and its lawyers “have (not) shown any remorse, admitted their wrongdoing or apologized to opposing counsel or the Court for their actions.” Many of the records that the company knowingly withheld were highly relevant and in some cases directly contradict testimony by Endo's witnesses, the judge wrote. ![]() The lower court judge already had held the company in contempt of court in May 2020 over discovery issues, including false statements.Įndo defended its efforts to address the judge's concerns, saying it hired an additional law firm, produced hundreds of thousands of additional documents and offered additional depositions at Endo’s expense.īut the judge said the company produced almost 400,000 documents after the discovery period closed, despite saying in February 2020 that it had not withheld anything. The same Supreme Court ruling said the local prosecutors can't be plaintiffs, so their corresponding cities and counties are in the process of being substituted into the case. The lawsuit seeks to hold the company liable under the Tennessee’s Drug Dealer Liability Act, a strategy the state Supreme Court said is allowed in a December 2020 opinion in a similar case. headquarters in Pennsylvania, is the last remaining active corporate defendant after Mallinckrodt and Purdue Pharma filed for bankruptcy. The plaintiffs of the 2017 lawsuit include three northeastern Tennessee district attorneys as well as a baby born addicted to opioids who is referred to as Baby Doe.Įndo, which has a U.S. “We look forward to putting our $2.4 billion damage case to a jury and ultimately seeing funds returned directly to these small communities, which have borne the brunt of Endo’s focus on financial gain,” said Gerard Stranch, managing partner of the firm representing the plaintiffs. The judge wrote they have “expert testimony that supports that amount.” The plaintiffs have sued for $2.4 billion. The company indicated Wednesday that it plans to appeal the judge's orders in the case, calling them “procedurally, factually, and legally deficient.” “Anything less would make a mockery of the attorneys who play by the rules and the legal system.” “Although this is a harsh sanction, justice demands it under the circumstances,” Moody wrote. More: This is how Tennessee's attorney general is waging war against opioid profiteering More: Tennessee Supreme Court to decide if Big Pharma can be sued as drug dealers The ruling finds the opioid manufacturer and another Endo subsidiary liable and sends the case right to a trial over damages. In the ruling, the judge cited a dozen falsehoods from Endo's legal team as the case played out. Moody entered the default judgment against Endo Pharmaceuticals, saying the company willfully withheld records during legal discovery to gain an edge at trial. In Sullivan County Circuit Court on Tuesday, Chancellor E.G. Watch Video: Watch how the number of opioid pills per person increased more than 50 percent in 6 years.Ī Tennessee judge has made a rare move to rule against an opioid firm before a civil trial over its role in the epidemic, saying there was a “coordinated strategy” by the company and its attorneys to delay proceedings, deprive plaintiffs of information and interfere with the administration of justice.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |